Dr. Barry Steven Wood, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2042 Beltline Rd Sw, Building B, Suite 103, Decatur, AL 35601 Phone: 256-350-0952 Fax: 256-350-0976 |
Dr. Carmen Lita Vargo-moncier, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: North Alabama Regional Hospital, 4218 Us Highway 31 South, Decatur, AL 35603 Phone: 256-560-2200 Fax: 256-560-2307 |
Dr. John R. Haney, PH.D. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 1615 Kathy Ln Sw, Decatur, AL 35603 Phone: 256-306-4146 Fax: 256-351-1424 |
News Archive
A drug developed and tested at UAB (University of Alabama at Birmingham) targeted at malignant brain tumors known as glioma has shown promising results in a Phase 1 trial, according to results presented at the American Society for Therapeutic Radiology and Oncology annual meeting.
Scientists have determined that fungus may play a key role in chronic intestinal inflammation disorders. They found that patients with Crohn's disease tend to have much higher levels of the fungus Candida tropicalis compared to their healthy family members.
Ex-prisoners with a history of risky drug use, mental illness or poverty are more likely to end up back behind bars. Those who are obese, are chronically ill or have attempted suicide are more likely to remain in the community. These are some of the findings from an exploratory study into health-related factors that could be used to predict whether a person released from prison will end up in custody again.
Parents want to make sure their children are getting the nutrients they need to grow and thrive but sometimes it's easier said than done. According to a recent Leger Marketing survey of Canadians parents with children between the ages of three to 12 conducted on behalf of Jamieson Laboratories, almost sixty per cent of parents say their children are picky eaters with the same percentage of parents concerned their children aren't getting the proper nutrients they need for growth and development.(1)
Many gene therapy-based approaches are in development to combat genetic and other causes of blindness and vision loss, and much can be learned about the safety and effectiveness of these promising new therapies by studying them first in non-human primates before initiating clinical trials, as shown by the results of a study published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 8 days ago